Madison Hughes

Stu Wein speaks with Madison Hughes about his experience with stage II breast cancer and subsequent reconstruction surgery.

Pallav K. Mehta, MD, spoke with LBBC about the changes he’s seen in 15 years of treating metastatic hormone receptor-positive breast cancer, and what people should know about their diagnosis and treatment.

The Food and Drug Administration approved the targeted therapy alpelisib (Piqray) to treat certain hormone receptor-positive, HER2-negative breast cancers in postmenopausal women and in men.

Charmaine Chan, DO, a family doctor who was diagnosed with breast cancer at age 40, speaks to LBBC about why she leads a team for Reach & Raise every year.

As a student at Tufts University, Lilly Bolen started the Play for Pink event, raising money for LBBC in honor of her mother, Lauren, who died of breast cancer in 2017.

Bev Parker has been dealing with lymphedema since 1986, she shares some of the challenges and tips for managing the condition.

Susan Jacobson's experience searching for accurate information about her 2015 breast cancer diagnosis inspired her, a professional of journalism, to turn her research to fake and misleading health news online.

The support of Donna Noce Colaco and Frank Colaco for LBBC's mission has been a model of philanthropic leadership, and that support is honored with the renaming of the Donna Noce Colaco Going Beyond Award.

Acupuncture is one form of complementary and integrative medicine, a collection of therapies used along with conventional treatment to help ease side effects from cancer treatments

PARP inhibitor is the second approved for use in HER2-negative breast cancer in people who carry a BRCA mutation.